Back to dashboard
CommercialPrior AuthHigh impact

Parenteral Immunoglobulins (CPB 0206, reviewed 2026-06-18)

Aetna·Allergy & Immunology, Infectious Disease, Hematology +4 more·Medical Policy
Effective date
Jun 18, 2026
We identified it
Aug 13, 2026
Days to comply

Summary

Aetna updated its Parenteral Immunoglobulins policy (CPB 0206) effective June 18, 2026, establishing comprehensive precertification requirements and medical necessity criteria for IVIG and SCIG products across 28 specific brand names. All participating providers must obtain prior authorization before administering these immunoglobulins for commercial plans, with detailed clinical criteria for primary immunodeficiency, myasthenia gravis, CIDP, dermatomyositis/polymyositis, and ITP.

Action Required

Action needed
IMMEDIATELY (effective 2026-06-18): (1) Billing team must update clinical decision support in billing software to flag all IVIG and SCIG administrations for mandatory precertification before claims submission. (2) Create mandatory precertification workflow requiring providers to call (866) 752-7021 or fax (888) 267-3277 prior to any immunoglobulin infusion; use Specialty Pharmacy Precertification form for Statement of Medical Necessity (SMN). (3) Update encounter templates and order entry systems to display 28 brand names requiring precertification: Alyglo, Asceniv, Bivigam, Flebogamma DIF, Gammagard Liquid, Gammagard Liquid ERC, Gammagard S/D, Gammaked, Gammaplex, Gamunex-C, Octagam, Panzyga, Privigen, Qivigy, Yimmugo (IVIG); Cutaquig, Cuvitru, Hizentra, HyQvia, Xembify (SCIG). (4) Train all clinical and billing staff on the specific medical necessity criteria for each indication (primary immunodeficiency disorders, myasthenia gravis, CIDP, dermatomyositis/polymyositis, ITP) to ensure documentation supports precertification requests. (5) Implement site-of-care utilization management review per Aetna's related Site of Care policy for all IVIG/SCIG infusions. (6) Establish denial management protocol: claims submitted without precertification will be denied; coordinate with providers to obtain retroactive authorization if missed. (7) Update patient eligibility verification to flag Aetna commercial members requiring precertification notices at check-in.